The podcast explores the surge in popularity of GLP-1 weight-loss drugs like semaglutide (Ozempic, Wegovy), their availability through compounding pharmacies, and emerging psychological side effects such as emotional flatness and loss of motivation. While these drugs offer life-changing b
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Dr. Sarah Lavelle
conversational on Today, Explained
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Topics
Listen to This Episode
More from Today, Explained
Packing in protein
Testosterone is all the rage
Pushing peptides
Going broke on wellness
The steroid olympics
The perimenopause moment
Related episodes
From other shows on similar topics.
People are running their own experiments with GLP-1s — with stunning results
Apple News Today
What we got wrong about GLP-1s
Search Engine
Reshaping the GLP-1 Economy: A Breaking Consumer Study
We Fixed It, You're Welcome
Ozempic for All?
The Daily
How Big Food Is Navigating the GLP-1 Era
The Journal.
Rethinking addiction in the age of Ozempic
TED Radio Hour
Get summaries like this every morning.
Free AI-powered recaps of Today, Explained and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.